Peptide Dose Tracker

How Long Do Semaglutide Side Effects Last?

The labels tell you most nausea, vomiting and diarrhea came during dose escalation123. In one pooled trial analysis, the median nausea episode lasted 8 days4.

What the labels say about timing

If you are asking how long semaglutide side effects last, the labels answer with timing, not a number of days. The Ozempic label, dated June 2026, puts most of those reports during dose escalation1. As of August 2026, the Zepbound and Mounjaro labels say most nausea, vomiting and diarrhea happened during dose escalation and decreased over time23. Copy the phrase exactly and keep the product name with it.

The Wegovy label version read for this page, dated June 18, 2026, gives no duration5. You can compare it with side effect rates in FDA labels.

What a pooled trial analysis reports

A 2022 paper, published online in 2021, pooled three 68-week semaglutide trials, numbered 1 to 34. Median episodes lasted 8 days for nausea, 3 for diarrhea, 2 for vomiting and 47 for constipation, versus 35 on placebo4. These are trial medians, not your number.

Most gastrointestinal events were mild to moderate, at 98.1%, and happened most often during or shortly after dose escalation4. Of participants on semaglutide, 4.3% stopped treatment because of them4. Novo Nordisk A/S funded the trials4.

Why this page cannot tell you your number

As of September 16, 2025, FDA says it does not review compounded drugs for effectiveness or quality before they are marketed6. The label wording and trial numbers here describe approved products. Trials, products and people differ, so none of it is a forecast for you. In your notes, keep label facts, trial medians, injection site reactions in labels and dated FDA alerts in separate sections.

What the Medication Guide says to do

The Medication Guides say to talk to your healthcare provider about any side effect that bothers you or does not go away25. They also print FDA's reporting number, 1-800-FDA-1088. That number reaches MedWatch, FDA's route for patients and clinicians to report adverse events and product quality problems7.

In an emergency, call 911. Poison Help is 1-800-222-1222, as listed on October 12, 20268.

Note when it gets easier

Use Note it in your log when it got easier for a dated note beside your own entries. Keep it in the side effect log, or next to a GLP-1 tracker or peptide tracker.

Read this first. Information only, not medical advice. This site does not recommend amounts. Talk to your prescriber or pharmacist about your own situation. 18+. Questions about your medicine, symptoms or a reaction? Contact your clinician or pharmacist. In an emergency, call 911. Poison Help: 1-800-222-1222.

Editorial review against cited sources. Last checked Oct 12, 2026.

Sources

  1. DailyMed: Ozempic label (opens in a new tab), FDA-reviewed label posted on DailyMed (U.S. National Library of Medicine), labeler Novo Nordisk. SPL version 20, label effective 2026-06-01 (Prescribing Information revised June 2026); DailyMed listing posted Jun 10, 2026.
  2. DailyMed: Zepbound label (opens in a new tab), FDA-reviewed label posted on DailyMed (U.S. National Library of Medicine), labeler Eli Lilly and Company. SPL version 40, label effective 2026-08-28 (Prescribing Information revised 08/2026); DailyMed listing posted Sep 02, 2026.
  3. DailyMed: Mounjaro label (opens in a new tab), FDA-reviewed label posted on DailyMed (U.S. National Library of Medicine), labeler Eli Lilly and Company. SPL version 40, label effective 2026-08-27 (Prescribing Information revised August 2026); DailyMed listing posted Sep 02, 2026.
  4. Wharton et al. 2022: tolerability of once-weekly semaglutide (opens in a new tab), Wharton S, Calanna S, Davies M, et al. Diabetes, Obesity and Metabolism 2022;24(1):94-105 (open access on PubMed Central). Published online 10/04/2021; doi:10.1111/dom.14551.
  5. DailyMed: Wegovy label (opens in a new tab), FDA-reviewed label posted on DailyMed (U.S. National Library of Medicine), labeler Novo Nordisk. SPL version 19, label effective 2026-06-18 (Medication Guide revised 06/2026); DailyMed listing posted Jun 30, 2026.
  6. FDA: Compounding and the FDA, questions and answers (opens in a new tab), U.S. Food and Drug Administration. Content current as of 09/16/2025.
  7. FDA: MedWatch adverse event reporting (opens in a new tab), U.S. Food and Drug Administration. Program page (no page date).
  8. Poison Help (America's Poison Centers) (opens in a new tab), America's Poison Centers (poison.org). Home page, read 10/12/2026.